ConductScience.org, home

Paper38587293

High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort.

Barritt AS and 8 others. Am J Gastroenterol, 2024. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort. Papers, record 38587293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38587293

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort.
PubMed
Journal
Am J Gastroenterol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
3.51, provisional
iCite
Revised in PubMed
2026-05-06
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Barritt AS 4thA Sidney
2Yu FFenghttps://orcid.org/0000-0002-7844-6534
3Mospan ARAndrea Rhttps://orcid.org/0000-0002-3419-8276
4Newsome PNPhillip Nhttps://orcid.org/0000-0001-6085-3652
5Roden MMichaelhttps://orcid.org/0000-0001-8200-6382
6Morris HLHeather Lhttps://orcid.org/0000-0002-7540-5315
7Loomba RRohithttps://orcid.org/0000-0002-4845-9991
8Neuschwander-Tetri BABrent Ahttps://orcid.org/0000-0002-8520-7398
9TARGET-NASH investigatorsGroup

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Non-alcoholic Fatty Liver DiseaseMajor topic
Humans
Female
Male
Middle Aged
Adult
Terminology as Topic
Liver Cirrhosis
Cohort Studies
Aged
Fatty Liver
United States

Source PubMed

Download CSV of topics

Grants9

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
Target RWEPubMedPubMed
UL1 TR001442NCATS NIH HHSUnited StatesUL1TR001442PubMedNIH RePORTER
U01 DK061734NIDDK NIH HHSUnited StatesU01DK061734PubMedNIH RePORTER
U01 DK130190NIDDK NIH HHSUnited StatesU01DK130190PubMedNIH RePORTER
R01 DK106419NIDDK NIH HHSUnited StatesR01DK106419PubMedNIH RePORTER
R01 DK121378NIDDK NIH HHSUnited StatesR01DK121378PubMedNIH RePORTER
R01 DK124318NIDDK NIH HHSUnited StatesR01DK124318PubMedNIH RePORTER
P30 DK120515NIDDK NIH HHSUnited StatesP30DK120515PubMedNIH RePORTER
P01 HL147835NHLBI NIH HHSUnited StatesP01HL147835PubMedNIH RePORTER

Download CSV of grants

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
42846528Low Serum Adiponectin May Identify MASLD as a Comorbidity in Patients with Moderate-to-Severe Psoriasis.Psoriasis (Auckl)2026https://conductscience.org/library/papers/42846528PubMed
42732142What is the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on outcomes in people living with chronic hepatitis B (CHB)? An umbrella review protocol.Wellcome Open Res2026https://conductscience.org/library/papers/42732142PubMed
42690133Prognostic value of liver histology in steatotic liver disease: a systematic literature review and meta-analysis.J Comp Eff Res2026https://conductscience.org/library/papers/42690133PubMed
42346825Comparative Post-Transplant Outcomes in Alcohol-Related Liver Disease and Non-Alcohol Steatohepatitis: A Multicenter Propensity-Matched Study.Med Sci (Basel)2026https://conductscience.org/library/papers/42346825PubMed
42104084Diagnosing and defining MASLD in people living with chronic hepatitis B.Commun Med (Lond)2026https://conductscience.org/library/papers/42104084PubMed
41614714Association Between Oral Health and Metabolic Dysfunction-Associated Steatotic Liver Disease Among US Adults.Clin Transl Gastroenterol2026https://conductscience.org/library/papers/41614714PubMed
41360893Comparison of prevalence of fatty liver disease according to the different nomenclatures of NAFLD, MAFLD, and MASLD in a large Iranian Population-based study.Sci Rep2025https://conductscience.org/library/papers/41360893PubMed
41104541Reclassifying pediatric NAFLD using the steatotic liver disease framework: A multicenter retrospective study from the NASH CRN.Hepatology2026https://conductscience.org/library/papers/41104541PubMed
41066381Metabolic comorbidities and post-transplant outcomes in Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD): a cohort study from a Brazilian tertiary center.Arch Endocrinol Metab2025https://conductscience.org/library/papers/41066381PubMed
40775615Predictive factors for metabolic syndrome in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).BMC Gastroenterol2025https://conductscience.org/library/papers/40775615PubMed
40475116Revisiting MASLD Nomenclature: Insights from the MENA Region and Its Clinical Relevance.J Clin Exp Hepatol2025https://conductscience.org/library/papers/40475116PubMed
40371650Disease classification, diagnostic challenges, and evolving clinical trial design in MASLD.J Clin Invest2025https://conductscience.org/library/papers/40371650PubMed
39957372
Metabolic dysfunction in patients following DAA-induced viral cure for HCV infection: A non-negligible risk to liver-related health: Editorial on "Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C".
Clin Mol Hepatol2025https://conductscience.org/library/papers/39957372PubMed
39739194Understanding MASH: An Examination of Progression and Clinical Outcomes by Disease Severity in the TARGET-NASH Database.Adv Ther2025https://conductscience.org/library/papers/39739194PubMed
39678071Statin Therapy is Associated With Lower Risk of Mortality Among Liver Transplant Candidates With Metabolic Dysfunction-associated Steatohepatitis.J Clin Exp Hepatol2025https://conductscience.org/library/papers/39678071PubMed
39018024The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints.Am J Gastroenterol2025https://conductscience.org/library/papers/39018024PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38587293

GET https://conductscience.org/api/papers/v1/38587293/authors